<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Norihito Sasaki</style></author><author><style face="normal" font="default" size="100%">Mitsushige Murata</style></author><author><style face="normal" font="default" size="100%">Yiru Guo</style></author><author><style face="normal" font="default" size="100%">Su-Hyun Jo</style></author><author><style face="normal" font="default" size="100%">Andreas Ohler</style></author><author><style face="normal" font="default" size="100%">Masaharu Akao</style></author><author><style face="normal" font="default" size="100%">Brian O'Rourke</style></author><author><style face="normal" font="default" size="100%">Rui-Ping Xiao</style></author><author><style face="normal" font="default" size="100%">Roberto Bolli</style></author><author><style face="normal" font="default" size="100%">Eduardo Marbán</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning</style></title><secondary-title><style face="normal" font="default" size="100%">Circulation</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2003</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/12615799</style></url></web-urls></urls><pages><style face="normal" font="default" size="100%">1183-1188</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">8</style></issue><custom7><style face="normal" font="default" size="100%">000181466900018</style></custom7></record></records></xml>